Hospital admissions linked to SARS-CoV-2 infection in children and adolescents: cohort study of 3.2 million first ascertained infections in England.
Journal
BMJ (Clinical research ed.)
ISSN: 1756-1833
Titre abrégé: BMJ
Pays: England
ID NLM: 8900488
Informations de publication
Date de publication:
05 07 2023
05 07 2023
Historique:
medline:
7
7
2023
pubmed:
6
7
2023
entrez:
5
7
2023
Statut:
epublish
Résumé
To describe hospital admissions associated with SARS-CoV-2 infection in children and adolescents. Cohort study of 3.2 million first ascertained SARS-CoV-2 infections using electronic health care record data. England, July 2020 to February 2022. About 12 million children and adolescents (age <18 years) who were resident in England. Ascertainment of a first SARS-CoV-2 associated hospital admissions: due to SARS-CoV-2, with SARS-CoV-2 as a contributory factor, incidental to SARS-CoV-2 infection, and hospital acquired SARS-CoV-2. 3 226 535 children and adolescents had a recorded first SARS-CoV-2 infection during the observation period, and 29 230 (0.9%) infections involved a SARS-CoV-2 associated hospital admission. The median length of stay was 2 (interquartile range 1-4) days) and 1710 of 29 230 (5.9%) SARS-CoV-2 associated admissions involved paediatric critical care. 70 deaths occurred in which covid-19 or paediatric inflammatory multisystem syndrome was listed as a cause, of which 55 (78.6%) were in participants with a SARS-CoV-2 associated hospital admission. SARS-CoV-2 was the cause or a contributory factor in 21 000 of 29 230 (71.8%) participants who were admitted to hospital and only 380 (1.3%) participants acquired infection as an inpatient and 7855 (26.9%) participants were admitted with incidental SARS-CoV-2 infection. Boys, younger children (<5 years), and those from ethnic minority groups or areas of high deprivation were more likely to be admitted to hospital (all P<0.001). The covid-19 vaccination programme in England has identified certain conditions as representing a higher risk of admission to hospital with SARS-CoV-2: 11 085 (37.9%) of participants admitted to hospital had evidence of such a condition, and a further 4765 (16.3%) of participants admitted to hospital had a medical or developmental health condition not included in the vaccination programme's list. Most SARS-CoV-2 associated hospital admissions in children and adolescents in England were due to SARS-CoV-2 or SARS-CoV-2 was a contributory factor. These results should inform future public health initiatives and research.
Identifiants
pubmed: 37407076
doi: 10.1136/bmj-2022-073639
pmc: PMC10318942
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e073639Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: support by the British Heart Foundation Data Science Centre led by Health Data Research UK. CP is a member of Independent Sage and received no funding in relation to this role. HKK is deputy chair and clinical advisor for the Paediatric Intensive Care Audit Network. PR is chair of the Paediatric Critical Care Society Study Group. KB is co-chair of the Paediatric Critical Care Society Cardiac Group. The authors declare no financial relationships with any organisations that might have an interest in the submitted work in the previous three years.
Références
J Clin Endocrinol Metab. 2022 Jul 14;107(8):e3264-e3272
pubmed: 35524727
J Clin Med. 2022 Feb 07;11(3):
pubmed: 35160328
Arch Dis Child. 2016 Oct;101(10):881-5
pubmed: 27246068
Lancet Reg Health Eur. 2021 Apr;3:100075
pubmed: 34027512
BMJ. 2020 Aug 27;370:m3249
pubmed: 32960186
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):146-152
pubmed: 35085225
JAMA Pediatr. 2021 Sep 1;175(9):928-938
pubmed: 34152371
Stat Med. 1998 Feb 28;17(4):407-29
pubmed: 9496720
Euro Surveill. 2021 Dec;26(50):
pubmed: 34915968
J Hosp Med. 2021 Oct;16(10):603-610
pubmed: 34613896
Nat Med. 2022 Jan;28(1):185-192
pubmed: 34764489
Pediatr Radiol. 2022 May;52(6):1038-1047
pubmed: 35394163
Acta Paediatr. 2022 Mar;111(3):467-472
pubmed: 34751972
Lancet Child Adolesc Health. 2020 Sep;4(9):669-677
pubmed: 32653054
PLoS Med. 2022 Nov 8;19(11):e1004118
pubmed: 36346784
Crit Care. 2021 Nov 17;25(1):399
pubmed: 34789305
Pediatr Infect Dis J. 2022 Dec 1;41(12):989-993
pubmed: 36102705
J Infect. 2021 Nov;83(5):565-572
pubmed: 34474055
Lancet. 2020 May 23;395(10237):1607-1608
pubmed: 32386565
Pediatr Pulmonol. 2022 Feb;57(2):498-507
pubmed: 34779156
Lancet Respir Med. 2020 May;8(5):446-447
pubmed: 32224304
Nat Med. 2022 Jan;28(1):193-200
pubmed: 34931076
Eur J Pediatr. 2021 Nov;180(11):3343-3357
pubmed: 34037838
Lancet. 2022 Apr 2;399(10332):1303-1312
pubmed: 35305296
J Child Neurol. 2022 Apr;37(5):410-415
pubmed: 35286175
JAMA Pediatr. 2020 Sep 01;174(9):868-873
pubmed: 32392288
Lancet Child Adolesc Health. 2022 Jul;6(7):459-465
pubmed: 35526537
Stud Health Technol Inform. 2019 Jul 4;262:220-223
pubmed: 31349307
JAMA Pediatr. 2022 Aug 1;176(8):821-823
pubmed: 35675054
Blood Rev. 2022 May;53:100911
pubmed: 34838342
Eur J Pediatr. 2022 Oct;181(10):3635-3643
pubmed: 35962242
BMJ Open. 2018 Jun 22;8(6):e021015
pubmed: 29934386
Clin Neurol Neurosurg. 2021 Nov;210:106985
pubmed: 34700274
West J Emerg Med. 2021 May 07;22(3):603-607
pubmed: 34125034
MMWR Morb Mortal Wkly Rep. 2022 Mar 18;71(11):429-436
pubmed: 35298458
Lancet Digit Health. 2019 May 20;1(2):e63-e77
pubmed: 31650125
BMJ. 2021 Apr 7;373:n826
pubmed: 33827854
BMJ. 2020 May 22;369:m1985
pubmed: 32444460
J Prim Care Community Health. 2022 Jan-Dec;13:21501319221082351
pubmed: 35289210
Curr Treat Options Oncol. 2022 May;23(5):688-702
pubmed: 35334062
BMC Health Serv Res. 2021 Sep 23;21(1):1008
pubmed: 34556119